AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 386.00
Bid: 382.00
Ask: 384.50
Change: 22.00 (6.04%)
Spread: 2.50 (0.65%)
Open: 377.00
High: 392.00
Low: 377.00
Yest. Close: 364.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453

Thu, 3rd Sep 2020 21:27

Hutchison China Meditech Ltd - China-based biopharmaceutical company - Initiates a phase II study of HMPL-453, its novel small molecule inhibitor targeting fibroblast growth factor receptors, in patients with advanced intrahepatic cholangiocarcinoma, which is a type of liver cancer. The clinical study is a single-arm, multi-center, open-label study, evaluating the efficacy, safety and pharmacokinetics of HMPL-453 in patients with advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptors fusion that had failed at least one line of systemic therapy. The primary outcome measure is objective response rate. Secondary outcome evaluations include preliminary efficacy measures, such as disease control rate, time to response, duration of response, progression-free survival, and overall survival.

Current stock price: 508.00 pence

Year-to-date change: up 27%

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

4 May 21 20:25

TRADING UPDATES: STV looks to summer's football; In The Style sales up

TRADING UPDATES: STV looks to summer's football; In The Style sales up

29 Apr 21 14:34

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

21 Apr 21 16:02

IN BRIEF: Hutchison China gets USD100 million investment from Baring

IN BRIEF: Hutchison China gets USD100 million investment from Baring

8 Apr 21 15:57

IN BRIEF: Hutchison China starts first phase trials for HMPL-306

IN BRIEF: Hutchison China starts first phase trials for HMPL-306

29 Mar 21 20:20

TRADING UPDATES: Arden Partners to return to annual profitability

TRADING UPDATES: Arden Partners to return to annual profitability

24 Mar 21 16:44

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

4 Mar 21 12:46

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

25 Feb 21 16:19

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

UK TRADING UPDATE SUMMARY: Science Group To Beat Forecasts For 2020

11 Jan 21 14:51

IN BRIEF: Hutchison China Lands "Milestone" China Drug Green Light

IN BRIEF: Hutchison China Lands "Milestone" China Drug Green Light

30 Dec 20 22:05

Hutchison China Files US FDA Drug Application For Cancer Treatment

Hutchison China Files US FDA Drug Application For Cancer Treatment

29 Dec 20 12:31

IN BRIEF: Hutchison Chi-Med To Issue USD100 Million In Shares To CPP

IN BRIEF: Hutchison Chi-Med To Issue USD100 Million In Shares To CPP

17 Nov 20 19:31

UK TRADING UPDATE SUMMARY: Hutchison China Drug Application Accepted

UK TRADING UPDATE SUMMARY: Hutchison China Drug Application Accepted

17 Sep 20 21:35

Hutchison Chi-Med begins latest trial of fruquintinib

(Sharecast News) - Hutchison China MediTech, trading as Chi-Med, said on Friday that it has initiated 'FRESCO-2' - a phase 3 registration study of 'fruquintinib' for the treatment of patients with metastatic colorectal cancer (CRC) in the US, Europe and Japan.

4 Sep 20 14:13

IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453

IN BRIEF: Hutchison China Initiates Phase II Trial Of HMPL-453

3 Sep 20 21:27

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.